Immunocore’s Post

Reliability and reproducibility are essential for the credibility and efficiency of life sciences research, as well as the translation of research findings into meaningful clinical applications. Almaden Genomics’ g.nome® platform delivers traceable and reproducible results across your team and over time with robust version control and auto-generated process documentation, enabling you to meet key milestones and move seamlessly from discovery to production. g.nome provides simplified data exploration and effortless iteration so you have a higher probability of success in delivering breakthrough treatments to those in need. Learn more: https://lnkd.in/gBZvmA2H #personalizedmedicine #omicsanalysis #translationalresearch

On #RareDiseaseDay, let’s salute the efforts of researchers, scientists, and innovators pushing boundaries for rare conditions. Together let's continue the journey towards breakthroughs and brighter tomorrows. #ReimaginingMedicineTogether #rarediseaseday #spinalmuscularatrophy #sma

Academics hold key data and innovations driving the biomedical data revolution. Industry depends on these tools to uncover disease targets and predictive markers. Bridging academic science with industry needs could greatly boost R&D success. At #BioCenturyGrandRounds, The Human Data Revolution Session will explore how to make these data troves fit for purpose: ➤ Methods-for-purpose: Analytical tools that parse signal from noise, without flattening complexity ➤ Data-for-purpose: Go big, go deep, or go long? Speakers in this session include: ➤ Gonçalo Abecasis, Regeneron ➤ Amy Abernethy, former FDA ➤ Daniel Burkhardt, Cellarity ➤ David B. Goldstein, Actio Biosciences, Inc. ➤ Colin Hill, Aitia ➤ Mathai Mammen, M.D., Ph.D., FogPharma ➤ Elizabeth Ann Stringer, NashBio ➤ And more... Download the conference brochure to view the full agenda: https://loom.ly/TGB3Mmk Register: https://loom.ly/xUy6IGo #biomedicaldata #diseasetargets #markers #humandata

Each week we highlight five things affecting the life sciences industry. Here’s the latest.

Each week we highlight five things affecting the life sciences industry. Here’s the latest.

Each week we highlight five things affecting the life sciences industry. Here’s the latest.

In the field of life science and #DrugDiscovery, innovation and precision are key values. The advancements seen in this field are the result of the daily efforts of numerous experts at the intersection of #science and #technology. We interviewed developers who work with clients in the life science sector. Read insights from our conversation with Łukasz Zawada, and find more details in our article: https://lnkd.in/dGqJnwj9

The last day of Christmas & the last Christmas Special! 🎅 Standardization and optimization are important steps in any workflow, but in clinical applications they're essential. Oliver Kardell et al. showed just how important optimization and scientific exchange are. #massspec #proteomics Would you like to learn more, check out their #OpenAccess paper here http://pubmed.gov/38015820

Vital Science tells the stories behind the #science from the perspective of patients, scientists, employees, and advocated that have felt its impact. Listen and subscribe today. https://okt.to/bwzoHt

RECORDINGS POSTED for the Feb. and Mar. 2024 DIA RIM Intelligent Automation Team meetings. Both sessions featured example #generativeai capabilities: Feb. was Ari Caroline from Weave sharing an example of using #genai to help medical writers author submission documents and March was Jyotiska Biswas from ThinkTrends sharing an example of using #genai to search and summarize health authority requirements and guidances. DIA members can find the recording link in the Reg. Affairs Community site at the link below and under Library – RIM / Intelligent Automation folder. https://lnkd.in/eK67YNtH #diarim #intelligentautomation #rim #regulatory #regaffairs #regintel #ai #lifescience #pharma